RESUMEN
Esophageal cancer is a common malignant tumor of digestive system in China. Concurrent chemoradiotherapy has become the widely recognized method for the treatment of inoperable locally advanced esophageal carcinoma. Nevertheless, clinical efficacy of concurrent chemoradiotherapy remains to be enhanced. Nimotuzumab, the first human monoclonal antibody to treat malignant tumors in China, has been applied in the treatment of nasopharyngeal carcinoma, glioma, pancreatic cancer and other malignant tumors, which yields significant survival benefits and causes mild adverse events. Hence, more and more scholars are paying attention to its application value in the treatment of esophageal cancer. In this article, research progress on the application of nimotuzumab in esophageal cancer was reviewed, aiming to provide new ideas for the treatment of esophageal cancer.
RESUMEN
Objective To analyze the security of esomeprazole,amoxicillin and clarithromycin in the treatment of Hp associated gastric ulcer.Methods 96 cases of patients with Hp associated gastric ulcer in our hospital from June 2014 to June 2016 were selected,they were randomly divided into esomeprazole + amoxicillin + clarithromycin treatment group(esomeprazole group,n=48)and omeprazole + amoxicillin + clarithromycin treatment group(omeprazole group,n=48)two groups,the clinical symptom scores,clinical efficacy,Hp eradication and adverse reactions of the two groups were statistically analyzed.Results The abdominal pain,abdominal distension,belching,acid regurgitation scores of theesomeprazole group were significantly lower(P<0.05),the total treatment efficiency 95.8％(46/48)was significantly higher than the omeprazole group 72.9％(35/48)(P<0.05),the eradication rate of Hp 97.9％(47/48)was significantly higher than the omeprazole group 83.3％(40/48)(P<0.05),the adverse reaction rate 2.1％(1/48)was significantly lower than the omeprazole group 8.3％(4/48)(P<0.05).Conclusion The security of esomeprazole,amoxicillin and clarithromycin in the treatment of Hp associated gastric ulcer is higher thanomeprazole,amoxicillin and clarithromycin,so is worthy of promotion in the clinical.